BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  COVID-19 Vaccine To Commence Trials in Israel, Oral Version Underway

  Oramed Pharmaceuticals said that its majority-owned firm Oravax Medical would be spearheading the project, first in Israel and later in other international clinical locations.

  July 23, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Adverum Down After Clinical Development Shift for Gene Therapy Program

  Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME).

  July 23, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Despite Slow Launch, Biogen Touts $2 Million In Early Sales for Alzheimer’s Drug

  The company also issued an open letter to the Alzheimer’s disease community from Alfred Sandrock, which attempts to push back against negative media attention.

  July 23, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Breakthrough Discovery on Molecular “Noise” Could Enhance Stem Cell Therapies

  Scientists at Gladstone discovered a molecular mechanism that can manipulate random fluctuations, or “noise,” when stem cells transform into different other cells in the body.

  July 23, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  COVID-19 Surges in U.S., Lambda Variant and More Related News

  With COVID-19 resurging in the U.S., particularly in states with the lowest vaccination rates, additional news and research about the vaccines and the virus is coming out. Here’s a look.

  July 23, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Judge Orders Novartis to Cough Up $178 Million to Plexxikon Over Patent Infringements

  Novartis claimed the patents held by Plexxikon were invalid. Unfortunately for the company, the jury found it was unable to prove these claims.

  July 23, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  FDA

  FDA Greenlights AbbVie’s Antibiotic Dalvance for Acute Skin Infections in Children

  The U.S. Food and Drug Administration (FDA) approved AbbVie’s Dalvance (dalbavancin) for acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients as young as newborns.

  July 23, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Lisa Stockman Mauriello Receives First Tofersen Treatment - UPDATED

  Phase one launched last week after patients who had been on placebo in Biogen’s pivotal phase III VALOR study were transitioned to active therapy.

  July 23, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  FDA

  Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant

  The FDA has now approved AstraZeneca’s convenient once-a-week glucose lowering drug for 10 to 17-year-olds with type 2 diabetes.

  July 23, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  BioForest

  Clinical Catch-Up: July 19-23

  It was another busy week for clinical trial updates. Here’s a look at some including Mesoblast Limited, CytoDyn, Magenta Therapeutics and more.

  July 23, 2021

   · 

  6 min read

   · 

  Mark Terry